993
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Serum Thymidine Kinase 1 Protein Concentration for Predicting Early Progression and Monitoring the Response to TACE in Hepatocellular Carcinomas: a Network meta-analysis

, , , , ORCID Icon &
Article: FSO717 | Received 06 Feb 2021, Accepted 26 Apr 2021, Published online: 21 May 2021

References

  • FerlayJ , SoerjomataramI , SiegelRL , TorreLA , JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185, countries. CA Cancer J. Clin.68(6), 394–424 (2018).
  • TsochatzisEA , BoschJ , BurroughsAK. Liver cirrhosis. Lancet383(9930), 1749–1761 (2014).
  • SartoriusK , SwadlingL , AnPet al.The multiple roles of hepatitis B virus X protein (HBx) dysregulated microrna in hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) and immune pathways. Viruses12(7), 746 (2020).
  • ChenZQ , XieH , HuMMet al.Recent progress in treatment of hepatocellular carcinoma. Am. J. Cancer Res.10(9), 2993–3036 (2020).
  • KrishanS , DhimanRK , KalraNet al.Joint consensus statement of the Indian National Association for study of the liver and indian radiological and imaging association for the diagnosis and imaging of hepatocellular carcinoma incorporating liver imaging reporting and data system. J. Clin. Exp. Hepatol.9(5), 625–651 (2019).
  • KimTH , KimSY , TangA , LeeJM. Hepato Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin. Mol. Hepatol.25(3), 245–263 (2019).
  • LuoY , JiangY. Comparison of efficiency of TACE plus HIFU and TACE alone on patients with primary liver cancer. J. Coll. Physicians Surg. Pak.29(5), 414–417 (2019).
  • AleksandrovaK , BamiaC , DroganDet al.The association of coffee intake with liver cancer risk is mediated by biomarkers s of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr.102(6), 1498–1508 (2015).
  • EdooMIA , ChutturghoonVK , Wusu-AnsahGKet al.Serum biomarkers AFP, CEA and CA19-9 combined detection for early diagnosis of hepatocellular carcinoma. Iran. J. Public Health.48(2), 314–322 (2019).
  • BermanJJ , MooreGW. Precancer: The Beginning and the End of Cancer.Jones and Bartlett Publishers, MA, USA, 25–80 (2010).
  • SkogS , HeE , HaghdoostS. Prevention and early detection of human tumor. Lambert Academic Publishing, Schaltungsdienst Lange O.H.G., Berlin, 183–258 (2017). http://www. morebooks.de
  • WuJT. Circulating Tumor Markers of the New Millennium.AACC Press, NY, USA, 115–117 (2002).
  • WangY , JiangXR , WangSet al.Serological TK1 predict pre-cancer in routine health screenings of 56,178 people. Cancer Biomark.22(2), 237–247 (2018).
  • ErikssonS , Munch-PetersenB , JohanssonK , EklundH. Structure and function of cellular deoxyribonucleoside kinases. Cell. Mol. Life Sci.59(8), 1327–1346 (2002).
  • TopolcanO , HolubecLJr. The role of thymidine kinase in cancer diseases. Expert Opin. Med. Diagn.2(2), 129–141 (2008).
  • BitterEE , TownsendMH , EricksonR , AllenC , O'NeillKL. Thymidine kinase 1 through the ages: a comprehensive review. Cell Biosci.10(1), 138 (2020).
  • LouX , ZhouJ , MaHet al.The half-life of serum thymidine kinase 1 concentration is an important tool for monitoring surgical response in patients with lung Cancer: a meta-analysis. Genet. Test Mol. Biomarkers21(8), 471–478 (2017).
  • DangL , MaH-B , HeiAet al.A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment. Mol. Clin. Oncol.12(5), 440–450 (2020).
  • MaHB , HeiAL , ZhouJ , LiJ , HeE , SkogS. Serum thymidine kinase 1 as a biomarker for breast benign and malignant tumor risk assessment: a meta-analysis. Biomed. J. Sci. Tech. Res.30(3), 23341–233512020.
  • ChenZH , WangY , ChenGet al.Chapter 21 – Serum-biomarker thymidine kinase 1 for early discovery of tumor process of 160,086 participants using a sensitive immune-ECL-dot-blot detection system. In: Advances in Sensors: Reviews, V6.YurishSY ( Ed.). International Frequency Sensor Association Publishing, Barcelona, Spain, 529–540 (2018). http://www.sensorsportal.com
  • AiM , TaoC , WenJ. Significance of serum thymidine kinase 1 for primary liver cancer detection and monitoring the response to transarterial chemoembolization. Pract. Geriatr.26(5), 368–370 (2012).
  • AiM , WangJ , ShiH , XiaJ. Clinical value of TK1 in diagnosis of primary hepatic carcinoma with AFP negative and evaluation of interventional therapeutic efficacy. Jiangsu Med. J.41, 1939–1940 (2015).
  • ChenZR , HuangW , ChenLZ , LiDS. Diagnostic value of combined detection of serum α-fetoprotein, thymidine kinase 1 and dickkopf WNT signaling pathway inhibitor 1 in primary liver cancer. Oncol. Progress17(17), 2059–2066 (2019).
  • DingCZ , RenLi JF , ZhangCY. Study on contents of serum tumor markers in hepatocellular carcinoma patients and its correlation with apoptosis molecular and immune molecules in hepatocellular carcinoma tissue. JHMC21(5), 607–610 (2015).
  • DingXL , SunXQ , WuB , MaoZF , MaL. Significance of thymidine kinase 1 in HBsAg positive patients. J. Bengbu Med. College.44(5), 651–653 (2019).
  • FengQ. Comprehensive evaluation of the diagnostic value of four markers for primary hepatic carcinoma by ROC curve and Logistic regression. Labeled Immunoassay Clin. Med.23(6), 641–644 (2016).
  • GaoFL , WangJ , ShiH. Clinical significance of detection of serum thymidine kinase1 in patients with hepatocellular carcinoma. Jiangsu Med. J.40(6), 672–673 (2014).
  • GaoFL , HuangXZ. The value of combined detection of serum TK1 and AFP in the diagnosis of primary liver cancer. Contemp. Medical Symposium15(14), 135–136 (2017).
  • HongYL. Evaluation of the diagnostic and transarterial chemoembolization value of serum thymidine kinase 1 in patients with hepatocellular carcinoma. Contemp. Med.19(36), 94–95 (2013).
  • JiaSF , ChengJ , SuQ , YinH , YeY , LiJ. Expression levels of thymidine kinase 1 in patients with different clinical types of chronic HBV infection and the value of thymidine kinase 1 in early diagnosis of primary hepatocellular carcinoma. Chinese J. Pract. Internal Med.35(12), 1015–1018 (2015).
  • LiJ. Value of the combined detection of AFP, TK1 and DKK1 in the diagnosis of primary hepatic carcinoma. Gen. App. Biol.36(9), 3526–3531 (2017).
  • LiK , KongY. Changes in pre-and post-operative serum TK1 and AFP levels in patients with primary hepatocellular carcinoma undergoing arterial chemoembolization and its clinical significance. Chin. J. Clin. Oncol. Rehabil.24(10), 1172–1175 (2017).
  • LiZP , ZhangPA. The diagnostic value of serum AFP, TK1 and DKK1 in the detection of primary hepatocellular carcinoma. Modern J. Int. Trad. Chin. West. Med.25(1), 94–95 (2016).
  • LiZY , YangX , LiL. Effect of Doxorubicin and Lipiodol on the level of serum TK1, AFP and VEGF in patients with primary liver cancer. Sichuan Medical J.39(10), 1186–1190 (2018).
  • PeiQF , LiH. The clinical significance of serum APT, TK1 and HSP70 levels in the diagnosis of primary liver cancer. Labeled Immunoassays Clin. Med.24(10), 1119–1122 (2017).
  • QinJB , BoWB. Combined detection of AFG, TK1 and DKK1 in diagnosis of primary hepatocellular carcinoma. Chin. J. Clin. Lab. Sci.32(7), 545–547 (2014).
  • TangYP , XieY , CaiZ. Preoperative expression level of serum thymidine kinase 1 in hepatocellular carcinoma patients and its clinical significance. Guangxi Med. J.38(9), 1219–1221 (2016).
  • WangF , CuiS , WangFM. Serum thymidine kinase 1 is elevated and associated with BCLC stage in patients with hepatocellular carcinoma. World Chin. J Diges.25(20), 1861–1868 (2017).
  • WangQ , XieYW , XiaJ. Clinical value of combined detection of serum TK1, AFP, CEA in diagnosis of primary liver cancer. Int. J. Lab. Med.34(9), 1101–1102 (2013).
  • WangSJ , GuanJY , DingQ. The significance of serum thymidine kinase 1 test in evaluation after transcatheter arterial chemoembolization. J. Hepatobiliary Surg.26(3), 219–221 (2018).
  • XiaoJ. Effect of gemcitabine heat perfusion chemotherapy combined with carboplatin chemotherapy embolization on serum indexes in patients with hepatocellular carcinoma. J. Hainan Med. Univ.21(5), 829–834 (2015).
  • ZhangSY , LinBD , LiBR. Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma. FEBS Open Bio.5, 240–244 (2015).
  • ZhaoL , CaoMH , WangMX. Clinical significance of combined detection of serum tumor markers for differential diagnosis of intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Chin. J. Surg. Integ. Trad. West. Med.20(2), 123–126 (2014).
  • ZhengXW. Clinical value of thymidine kinase 1 in patients with hepatocellular carcinoma. Chin. J. School Doctor27(12), 936–937 (2013).
  • CaoX , ZhouJ , ChenZH. Standardized centile curves and reference intervals of serum thymidine kinase 1 levels in a normal chinese population using the LMS method. Genet. Test Mol. Biomarkers.20(8), 445–450 (2016).
  • KimY , AminiN , HeJet al.National trends in the use of surgery for benign hepatic tumors in the United States. Surgery157(6), 1055–1064 (2015).
  • AsraniSK , DevarbhaviH , EatonJ , KamathPS. Burden of liver diseases in the world. J. Hepatol.70(1), 151–171 (2019).
  • RouseB , ChaimaniA , LiT. Network meta-analysis: an introduction for clinicians. Intern. Emerg. Med.12(1), 103–111 (2017).
  • ZouL , ZhangP-G , ZouS , LiY , HeQ. The half-life of cytosolic thymidine kinase in serum by ECL dot bolt potential marker for monitoring the response to surgery of patients with gastric cancer. Internat. J. Biol. Markers.17(2), 135–140 (2012).
  • SaccoR , TapeteG , SimonettiNet al.Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review. J. Hepat. Carcino.4, 105–110 (2017).
  • WangY , JiangX , DongSet al.Serum TK1 is a more reliable marker than CEA and AFP for cancer screening survey in a study of 56,286 people. Cancer Biomark.16(4), 529–536 (2016).
  • HarringTR , GuiteauJJ , NguyenNTet al.Building a comprehensive genomic program for hepatocellular carcinoma. World J. Surg.35(8), 1746–1750 (2011).
  • LiuX , YangZ , TanHet al.Long-term result of transcatheter arterial embolization for liver haemangioma. Medicine (Baltimore)96(49), e9029 (2017).
  • ZhangW , HuangZY , KeC-Set al.Surgical treatment of giant liver hemangioma larger than 10 cm: a single center's experience with 86 patients. Medicine (Baltimore)94(34), e1420 (2015).
  • ValvaP , CasciatoP , LezamaCet al.Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. PLoS ONE8(1), e53519 (2013).
  • LiebigS , StoeckmannN , GeierAet al.Multicenter validation study of a diagnostic algorithm to detect NASH and fibrosis in NAFLD patients with low NAFLD fibrosis score or liver stiffness. Clin. Transl. Gastroenterol.10(8), e00066 (2019).
  • CiapponiA , BarreiraF , PerelliLet al.Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: a systematic review and meta-analysis. PLoS Negl. Trop. Dis.14(8), e0008529 (2020).
  • AhmadN , AhujaSD , AkkermanOWet al.Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017. Lancet392(10150), 821–834 (2018).
  • WangZX , ZhangGQ , LiZCet al.STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data. Future Sci. OA4.7(3), FSO661 (2020).